437 related articles for article (PubMed ID: 3091284)
1. Hyperthermia and phorbol ester tumor promotion in mouse skin.
Mitchel RE; Morrison DP; Gragtmans NJ; Jevcak JJ
Carcinogenesis; 1986 Sep; 7(9):1505-10. PubMed ID: 3091284
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenesis and carcinogenesis in mouse skin treated with hyperthermia during stage I or stage II of tumor promotion.
Mitchel RE; Morrison DP; Gragtmans NJ
Carcinogenesis; 1987 Dec; 8(12):1875-9. PubMed ID: 3119245
[TBL] [Abstract][Full Text] [Related]
3. The influence of a hyperthermia treatment on chemically induced tumor initiation and progression in mouse skin.
Mitchel RE; Morrison DP; Gragtmans NJ
Carcinogenesis; 1988 Mar; 9(3):379-85. PubMed ID: 3125992
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E is a complete tumor promoter in mouse skin.
Mitchel RE; McCann R
Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
[TBL] [Abstract][Full Text] [Related]
5. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
6. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
Slaga TJ; Fischer SM; Nelson K; Gleason GL
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term exposure to the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate on skin carcinogenesis in SENCAR mice.
Diwan BA; Ward JM; Henneman J; Wenk ML
Cancer Lett; 1985 Mar; 26(2):177-84. PubMed ID: 3919937
[TBL] [Abstract][Full Text] [Related]
9. Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.
Katiyar SK; Mohan RR; Agarwal R; Mukhtar H
Carcinogenesis; 1997 Mar; 18(3):497-502. PubMed ID: 9067548
[TBL] [Abstract][Full Text] [Related]
10. Induction of papillomas with a high probability of conversion to malignancy.
Hennings H; Shores R; Mitchell P; Spangler EF; Yuspa SH
Carcinogenesis; 1985 Nov; 6(11):1607-10. PubMed ID: 2414025
[TBL] [Abstract][Full Text] [Related]
11. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
Kruszewski FH; Conti CJ; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
Reiners JJ; Pavone A; Rupp T; Cantu AR
Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
[TBL] [Abstract][Full Text] [Related]
13. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin.
Hennings H
Basic Life Sci; 1991; 57():31-9; discussion 39-42. PubMed ID: 1814291
[TBL] [Abstract][Full Text] [Related]
14. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
[TBL] [Abstract][Full Text] [Related]
15. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
Ewing MW; Crysup SE; Phillips JL; Slaga TJ; DiGiovanni J
Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
18. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
20. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
Bhasin G; Kauser H; Athar M
Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
